Showing results (1881-1890 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|March 1, 2005
Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and managementJoseph M Pierre
Drug Safety|March 1, 2005
Protease inhibitor-induced diabetic complications : incidence, management and preventionLillian F Lien, Mark N Feinglos
Drug Safety|June 1, 2005
The precautionary principle and pharmaceutical risk managementTorbjörn Callréus
Drug Safety|June 1, 2005
Hormone replacement therapy and risk of acute myocardial infarction : a review of the literatureSusan E Bromley, Corinne S de Vries, Dawn Thomas, et al.
Drug Safety|June 1, 2005
Designing safe drug namesBruce L Lambert, Swu-Jane Lin, Hiangkiat Tan
Drug Safety|November 24, 2004
Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an exampleMargaret A Honein, Cynthia A Moore, J David Erickson
Drug Safety|March 24, 2005
Benefit-risk assessment of zaleplon in the treatment of insomniaJoseph Barbera, Colin Shapiro
Drug Safety|March 24, 2005
Vitex agnus castus: a systematic review of adverse eventsClaudia Daniele, Joanna Thompson Coon, Max H Pittler, et al.
Drug Safety|March 24, 2005
Safety profile of different low-molecular weight heparins used at therapeutic doseIsabelle Gouin-Thibault, Eric Pautas, Virginie Siguret
Drug Safety|February 5, 2005
Drugs, QT interval prolongation and ICH E14: the need to get it rightRashmi R Shah
Pageof 309